Articles
Articles
Improving Elderly Care Amid COVID-19 Concerns
As the COVID-19 pandemic continues to spread across America, the danger continues to rise for especially vulnerable populations such as those with underlying medical conditions and those who are older.
It is estimated that about 1.3 million Americans live in...
Articles
Transitioning to a New Normal: Healthcare in the Wake of the Coronavirus
The novel coronavirus pandemic is changing the way we access healthcare, with patients already beginning to engage with medical professionals and the industry in new ways. According to a recent report by PwC Health Research Insights - which compared...
Articles
How RTLS Systems Can Help Hospitals in Chaos
The COVID-19 outbreak is threatening to swamp hospitals across the United States. Some hospital systems are already beginning to reach capacity, and these facilities are focusing more and more effort on treating patients sick with the coronavirus.
The crisis is...
Articles
Healthcare 5.0 and the Age of Analytics
Data stands at the foundation for the future of healthcare as a valuable resource, with the boundless potential to alter the way healthcare is created, approached and delivered. Experiencing a paradigm shift of rapid change, Asia’s healthcare is entering...
Articles
COVID-19 is Here. What Impact Should We Expect on U.S. Healthcare Supply Chains?
COVID-19 is now solidly impacting the U.S. healthcare system. As the strategy shifts from containment to mitigation when dealing with the virus, what can we expect as the stress increases on healthcare supply chains? What can healthcare systems (particularly...
Articles
Preclinical imaging technology now driving cancer research
Over the last decade, equivalent multi-modal diagnostic imaging technologies routinely used in most hospitals and specialist clinics have become established as a significant part of a researcher’s analytical toolbox in oncology.
A key part of preclinical research is the construction...
Articles
The Power of Artificial Intelligence in Cancer Treatment: How the Democratization of Advanced New Treatment Options Benefits Patients, Doctors and Big Pharma
Cancer today impacts everyone.
As the second leading cause of death in the U.S., cancer will cause over 600,000 deaths in the country this year, with nearly 2 million new cases being diagnosed at the same time. The personal, professional,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
